Kethoxal Derivatives for Site-Specific Nucleic Acid Labeling

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for labeling nucleic acids lack specificity and efficiency in localizing therapeutic agents to their targets within cells, failing to covalently lock inhibitors in place or precisely target nucleic acid structures.

Innovation Solution

Development of kethoxal derivatives, such as N3-kethoxal, which selectively react with guanine bases in single-stranded DNA and RNA, enabling site-specific modification and covalent attachment of therapeutic agents using click chemistry, allowing for precise localization and enhanced efficacy of nucleic acid-based therapies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current labeling methods are used, then nucleic acids can be labeled, but the labeling lacks specificity and efficiency in localizing therapeutic agents to their targets

Engineering Contradiction:

Improvelabeling specificityVSAvoidlabeling efficiency

Core Design Contradiction:

Measurement precisionVSProductivity

Solution Approach 1:

The patent modifies the chemical structure of kethoxal derivatives by introducing specific substituents (e.g., N3 group at position 3, various R groups at position 2) to change their reactivity parameters. This enables selective reaction with guanine bases while maintaining efficient labeling, resolving the contradiction between specificity and efficiency

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The kethoxal derivative acts as an intermediary molecule that first reacts with guanine bases in nucleic acids, then serves as a handle for subsequent click chemistry reactions with therapeutic agents. This two-step process achieves both high specificity (through guanine selectivity) and high efficiency (through click chemistry ligation)

Inventive Principle:

Principle #24Intermediary (Mediator)

2Manufacturing precision

If kethoxal derivatives are used to selectively react with guanine bases, then site-specific modification is enabled, but the complexity of the chemical structure increases

Engineering Contradiction:

Improvesite-specific modificationVSAvoidchemical structure complexity

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The kethoxal derivative is segmented into distinct functional regions: the reactive kethoxal core that targets guanine, the R substituent that modulates reactivity and stability, and the E group that provides the click chemistry handle. This segmentation allows each part to be optimized independently for its specific function, achieving site-specificity without overwhelming complexity

Inventive Principle:

Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Kethoxal derivatives efficiently label guanines in nucleic acids, facilitating precise targeting and enhanced therapeutic effects by anchoring agents close to their binding sites, thereby increasing the effectiveness of nucleic acid-based treatments.

Implementation Method 1

Click chemistry kethoxal derivatives (e.g., N3-kethoxal) have been developed that efficiently couple to single-stranded DNAs and/or RNAs in live cells by reacting with the Watson-Crick interface of guanine bases

Methodology Applied

Scientific EffectClick chemistry: Chemical Bonding